Aton Ra Partners Seres Therapeutics, Inc. Transaction History

Aton Ra Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $193,032 - $799,000	-35,354 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $250,908 - $331,101	13,592 Added 62.46%	35,354 $843,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $85,986 - $140,811	4,869 Added 28.82%	21,762 $448,000
Q4 2020 Feb 19, 2021	BUY	$23.25 - $37.73 $392,762 - $637,372	16,893 New	16,893 $414,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.